{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:52:48Z","timestamp":1789419168174,"version":"build-2803163510"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Antidiabetic drugs are widely used in clinical practice as essential drugs for the treatment of diabetes. The effect of hypoglycemic drugs on erectile dysfunction has not been fully proven due to the presence of multiple confounding factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two-sample Mendelian randomization (TSMR) was used to examine the causal effect of antidiabetic drugs (including metformin, insulin and gliclazide) on erectile dysfunction. We used five robust analytic methods, of which the inverse variance weighting (IVW) method was the primary method, and also assessed factors such as sensitivity, pleiotropy, and heterogeneity. Effect statistics for exposures and outcomes were downloaded from publicly available data sets, including open Genome-Wide Association Studies (GWAS) and the UK Biobank (UKB).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In some of the hypoglycemic drug use, there was a significant causal relationship between metformin use and erectile dysfunction [Beta: 4.9386; OR:1.396E+02 (95% CI:9.13-2135); p-value: 0.0004), suggesting that metformin increased the risk of erectile dysfunction development. Also, we saw that gliclazide use also increased the risk of erectile dysfunction [Beta: 11.7187; OR:0.0125 (95% CI:12.44-1.21E+09); P value: 0.0125). There was no significant causal relationship between insulin use and erectile dysfunction [Beta: 3.0730; OR:21.6071 (95% CI:0.24-1942.38); p-value: 0.1806).Leave-one-out, MR-Egger, and MR-PRESSO analyses produced consistent results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The use of metformin and gliclazide have the potential to increase the risk of erectile dysfunction. There is no causal relationship between the use of insulin and erectile dysfunction.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1414958","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T04:45:03Z","timestamp":1724388303000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Causal association between antidiabetic drugs and erectile dysfunction: evidence from Mendelian randomization"],"prefix":"10.3389","volume":"15","author":[{"given":"Lin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Jinhua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Shulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Jiangping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Zhongxiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Xiaohong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01778.x","article-title":"Definitions\/epidemiology\/risk factors for sexual dysfunction","volume":"7","author":"Lewis","year":"2010","journal-title":"J sexual Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research","article-title":"Recent advances in the understanding and management of erectile dysfunction","volume":"8","author":"Krzastek","year":"2019","journal-title":"F1000Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/nrdp.2016.3","article-title":"Erectile dysfunction","volume":"2","author":"Yafi","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2007.00548.x","article-title":"Male erectile dysfunction: its prevalence in Western Australia and associated sociodemographic factors","volume":"5","author":"Chew","year":"2008","journal-title":"J sexual Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2004.00837.x","article-title":"The etiology of erectile dysfunction and contributing factors in different age groups in Turkey","volume":"11","author":"Caskurlu","year":"2004","journal-title":"Int J urology: Off J Japanese Urological Assoc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13403","article-title":"High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies","volume":"34","author":"Kouidrat","year":"2017","journal-title":"Diabet Med."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.2337\/dc22-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2018.10.004","article-title":"Diabesity and antidiabetic drugs","volume":"66","author":"Pappachan","year":"2019","journal-title":"Mol aspects Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.04.067","article-title":"Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial","volume":"56","author":"Batty","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"Bmj"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinf (Oxford England)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.607240","article-title":"Hypogonadism, type-2 diabetes mellitus, and bone health: A narrative review","volume":"11","author":"Russo","year":"2020","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12245","article-title":"Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction","volume":"10","author":"Labazi","year":"2013","journal-title":"J sexual Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.21037\/tau","article-title":"Effects of metformin on endothelial health and erectile dysfunction","volume":"6","author":"Patel","year":"2017","journal-title":"Trans andrology Urol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.111.013714","article-title":"Addition of metformin to sildenafil treatment for erectile dysfunction in eugonadal nondiabetic men with insulin resistance. A prospective, randomized, double-blind pilot study","volume":"33","author":"Rey-Valzacchi","year":"2012","journal-title":"J Androl"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/19971.8996","article-title":"Erectile dysfunction and low sex drive in men with type 2 DM: the potential role of diabetic pharmacotherapy","volume":"10","author":"Al-Kuraishy","year":"2016","journal-title":"J Clin Diagn research: JCDR"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4103\/ijnpnd.ijnpnd_83_19","article-title":"Erectile dysfunction and type 2 diabetes mellitus: A new twist","volume":"10","author":"Abdul-Hadi","year":"2020","journal-title":"Int J Nutrition Pharmacology Neurological Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.799290","article-title":"Metformin\u2019s effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study","volume":"13","author":"Tseng","year":"2022","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12480","article-title":"Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats","volume":"19","author":"Wang","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1568026620666191224141617","article-title":"Mechanisms and characteristics of sulfonylureas and glinides","volume":"20","author":"Lv","year":"2020","journal-title":"Curr topics medicinal Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(96)00626-1","article-title":"Effect of potassium channel modulators on male sexual behavior","volume":"60","author":"Benelli","year":"1997","journal-title":"Life Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.10.071","article-title":"Role of ATP-sensitive K+ channels in relaxation of penile resistance arteries","volume":"63","author":"Ruiz Rubio","year":"2004","journal-title":"Urology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901013","article-title":"Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells","volume":"15","author":"Insuk","year":"2003","journal-title":"Int J impotence Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.16.2159","article-title":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"290","year":"2003","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02720.x","article-title":"Investigation of the effects of the level of glycemic control on erectile function and pathophysiological mechanisms in diabetic rats","volume":"9","author":"Cho","year":"2012","journal-title":"J sexual Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/jcm10112501","article-title":"Role of glucose-lowering medications in erectile dysfunction","volume":"10","author":"Cignarelli","year":"2021","journal-title":"J Clin Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.111.014456","article-title":"The TGF-\u03b21\/Smad\/CTGF pathway and corpus cavernosum fibrous-muscular alterations in rats with streptozotocin-induced diabetes","volume":"33","author":"Zhou","year":"2012","journal-title":"J andrology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.180057","article-title":"Comparison of improving effects for diabetic erectile dysfunction according to the anti-glycemic agents: phlorizin and insulin","volume":"37","author":"Park","year":"2019","journal-title":"World J Mens Health"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1414958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T04:45:07Z","timestamp":1724388307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1414958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":43,"alternative-id":["10.3389\/fendo.2024.1414958"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1414958","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"article-number":"1414958"}}